Indeed, an increase in the IL-6 levels is seen in several neurological conditions, such as Alzheimer’s disease (AD), Parkinson’s disease, and Multiple Sclerosis [54,55,56], and elevated plasma levels of IL-6 increase the risk of developing dementia [57] and precedes the onset of AD [58]. This evidence concerns the gene IL6 and early-onset autosomal dominant Alzheimer disease.